Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Factor V Leiden, prothrombin 20210G>A, MTHFR 677C>T and 1298A>C, and homocysteinemia in Tunisian blood donors.

Hadhri S, Rejab MB, Guedria H, Ifa L, Chatti N, Skouri H.

J Clin Lab Anal. 2012 May;26(3):167-73. doi: 10.1002/jcla.21506.

PMID:
22628232
2.
3.

Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.

Kader HA, Berman WF, Al-Seraihy AS, Ware RE, Ulshen MH, Treem WR.

J Pediatr Gastroenterol Nutr. 2002 Nov;35(5):629-35.

PMID:
12454577
5.

Effects of MTHFR c.677C>T, F2 c.20210G>A and F5 Leiden Polymorphisms in Gastroschisis.

Makhmudi A, Sadewa AH, Aryandono T, Chatterjee S, Heij HA, Gunadi.

J Invest Surg. 2016;29(2):88-92. doi: 10.3109/08941939.2015.1077908. Epub 2015 Sep 16.

PMID:
26375922
6.

No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.

Bezemer ID, Doggen CJ, Vos HL, Rosendaal FR.

Arch Intern Med. 2007 Mar 12;167(5):497-501.

PMID:
17353498
7.

Factor V Leiden, prothrombin 20210G --> A, methylenetetrahydrofolate reductase 677C --> T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism.

Meglic L, Stegnar M, Milanez T, Bozic M, Peterlin B, Peternel P, Novak-Antolic Z.

Eur J Obstet Gynecol Reprod Biol. 2003 Dec 10;111(2):157-63.

PMID:
14597244
8.

Impact of thrombogenic mutations on clinical phenotypes of von Willebrand disease.

Ahmad F, Kannan M, Yadav V, Biswas A, Saxena R.

Clin Appl Thromb Hemost. 2010 Jun;16(3):281-7. doi: 10.1177/1076029609351291. Epub 2009 Dec 2.

PMID:
19959486
9.

A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.

Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N.

J Thromb Thrombolysis. 2005 Jun;19(3):189-96.

PMID:
16082606
10.

Prevalence of genetic thrombophilic polymorphisms in the Sri Lankan population--implications for association study design and clinical genetic testing services.

Dissanayake VH, Weerasekera LY, Gammulla CG, Jayasekara RW.

Exp Mol Pathol. 2009 Oct;87(2):159-62. doi: 10.1016/j.yexmp.2009.07.002. Epub 2009 Jul 8.

PMID:
19591822
11.

Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.

Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M.

J Vasc Surg. 2005 May;41(5):808-15.

12.

Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss.

Kutteh WH, Park VM, Deitcher SR.

Fertil Steril. 1999 Jun;71(6):1048-53.

PMID:
10360908
13.

The early-onset preeclampsia is associated with MTHFR and FVL polymorphisms.

Salimi S, Saravani M, Yaghmaei M, Fazlali Z, Mokhtari M, Naghavi A, Farajian-Mashhadi F.

Arch Gynecol Obstet. 2015 Jun;291(6):1303-12. doi: 10.1007/s00404-014-3561-5. Epub 2014 Dec 6.

PMID:
25480409
14.

Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.

Rahimi Z, Nomani H, Mozafari H, Vaisi-Raygani A, Madani H, Malek-Khosravi S, Parsian A.

Blood Coagul Fibrinolysis. 2009 Jun;20(4):252-6. doi: 10.1097/MBC.0b013e3283255487.

PMID:
19349859
15.

Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors.

Antoniadi T, Hatzis T, Kroupis C, Economou-Petersen E, Petersen MB.

Am J Hematol. 1999 Aug;61(4):265-7.

16.

The prevalence of methylenetetrahydrofolate reductase 677 C-T, factor V 1691 G-A, and prothrombin 20210 G-A mutations in healthy populations in Setif, Algeria.

Bourouba R, Houcher B, Djabi F, Egin Y, Akar N.

Clin Appl Thromb Hemost. 2009 Oct;15(5):529-34. doi: 10.1177/1076029608319944. Epub 2008 Oct 7.

PMID:
18840629
17.

PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events in central Iran.

Pourgheysari B, Boroujeni HR, Hasheminia AM, Drees F.

Blood Coagul Fibrinolysis. 2013 Jul;24(5):471-6. doi: 10.1097/MBC.0b013e32835e4260.

PMID:
23358226
18.

Primer-engineered multiplex PCR-RFLP for detection of MTHFR C677T, prothrombin G20210A and factor V Leiden mutations.

Koksal V, Baris I, Etlik O.

Exp Mol Pathol. 2007 Aug;83(1):1-3. Epub 2006 Dec 30.

PMID:
17275807
19.

MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.

Mtiraoui N, Ezzidi I, Chaieb M, Marmouche H, Aouni Z, Chaieb A, Mahjoub T, Vaxillaire M, Almawi WY.

Diabetes Res Clin Pract. 2007 Jan;75(1):99-106. Epub 2006 Jul 7.

PMID:
16828193
20.

No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene.

Rintelen C, Mannhalter C, Lechner K, Eichinger S, Kyrle PA, Papagiannopoulos M, Schneider B, Pabinger I.

Blood Coagul Fibrinolysis. 1999 Mar;10(2):101-5.

PMID:
10192659

Supplemental Content

Support Center